ES5 RIMONABANT FOR THE TREATMENT OF OVERWEIGHT AND OBESE INDIVIDUALS AT INCREASED CARDIOMETABOLIC RISK-AN ECONOMIC EVALUATION USING DISCRETE EVENT SIMULATION
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63191-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63191-9/fulltext
Section Title :
Section Order :
42
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63191-9&doi=10.1016/S1098-3015(10)63191-9